Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression

NCT01401192 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

304

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Gemcitabine plus cisplatin
DRUG: pemetrexed plus cisplatin
DRUG: pemetrexed plus cisplatin
DRUG: Gemcitabine plus cisplatin

Sponsor

Samsung Medical Center